These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7881195)

  • 1. Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):211-28. PubMed ID: 7881195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug kinetics and drug resistance in optimal chemotherapy.
    Costa MI; Boldrini JL; Bassanezi RC
    Math Biosci; 1995 Feb; 125(2):191-209. PubMed ID: 7881194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic treatments: a study of the interplay among drug resistance, toxicity and recuperation from side effects.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Mar; 59(2):205-32. PubMed ID: 9116600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conflicting objectives in chemotherapy with drug resistance.
    Costa MI; Boldrini JL
    Bull Math Biol; 1997 Jul; 59(4):707-24. PubMed ID: 9214850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal chemotherapy: a case study with drug resistance, saturation effect, and toxicity.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1994; 11(1):45-59. PubMed ID: 8057040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mathematical model of drug resistance: heterogeneous tumors.
    Panetta JC
    Math Biosci; 1998 Jan; 147(1):41-61. PubMed ID: 9401351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal chemical control of populations developing drug resistance.
    Costa MI; Boldrini JL; Bassanezi RC
    IMA J Math Appl Med Biol; 1992; 9(3):215-26. PubMed ID: 1295929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of optimal control theory in cancer chemotherapy.
    Swan GW
    Math Biosci; 1990 Oct; 101(2):237-84. PubMed ID: 2134485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mathematic models for cancer chemotherapy: pharmacokinetic and cell kinetic considerations.
    Chuang S
    Cancer Chemother Rep; 1975; 59(4):827-42. PubMed ID: 1175173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle.
    Murray JM
    Math Biosci; 1994 Oct; 123(2):183-213. PubMed ID: 7827419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some optimal control problems in cancer chemotherapy with a toxicity limit.
    Murray JM
    Math Biosci; 1990 Jun; 100(1):49-67. PubMed ID: 2134468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy--theory and practice.
    Capizzi RL; Keiser LW; Sartorelli AC
    Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy.
    Boldrini JL; Costa MI
    IMA J Math Appl Med Biol; 2000 Mar; 17(1):33-51. PubMed ID: 10757031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of optimal drug administration strategies for cancer-chemotherapy in the framework of systems theory.
    Acharya RS; Sundareshan MK
    Int J Biomed Comput; 1984; 15(2):139-50. PubMed ID: 6724730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regrowth resistance in cancer: why has it been largely ignored?
    Preisler HD; Venugopal P
    Cell Prolif; 1995 Jun; 28(6):347-56. PubMed ID: 7626689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal control of tumor size used to maximize survival time when cells are resistant to chemotherapy.
    Martin RB; Fisher ME; Minchin RF; Teo KL
    Math Biosci; 1992 Jul; 110(2):201-19. PubMed ID: 1498450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal chemotherapy regimens: influence of tumours on normal cells and several toxicity constraints.
    Matveev AS; Savkin AV
    IMA J Math Appl Med Biol; 2001 Mar; 18(1):25-40. PubMed ID: 11339336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A delay differential equation model for tumor growth.
    Villasana M; Radunskaya A
    J Math Biol; 2003 Sep; 47(3):270-94. PubMed ID: 12955460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment.
    Panetta JC
    Bull Math Biol; 1996 May; 58(3):425-47. PubMed ID: 8688836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of biguanides to improve response to chemotherapy.
    Sandulache VC; Yang L; Skinner HD
    Methods Mol Biol; 2014; 1165():3-9. PubMed ID: 24839014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.